Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyashita, T.
Right arrow Articles by Kuro, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyashita, T.
Right arrow Articles by Kuro, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 15, No. 6, 507-513 (2000)
DOI: 10.1177/026765910001500606

Preservation of collagen-induced whole blood platelet aggregation by tranexamic acid therapy in primary cardiac valve surgery

Tetsuya Miyashita

Department of Anaesthesiology, National Cardiovascular Center, Osaka, tetsuyam{at}med.yokohama-cu.ac.jp

Takahiko Kamibayashi

Department of Anaesthesiology, National Cardiovascular Center, Osaka

Yoshihiko Ohnishi

Department of Anaesthesiology, National Cardiovascular Center, Osaka

Junjiro Kobayashi

Department of Anaesthesiology, National Cardiovascular Center, Osaka

Masakazu Kuro

Department of Anaesthesiology, National Cardiovascular Center, Osaka

Haemostatic disorder is one of the most common complications following cardiac surgery with cardiopulmonary bypass (CPB). Tranexamic acid reduces blood loss and allogeneic blood transfusion requirement in cardiac surgery. It had been thought that tranexamic acid inhibited fibrinolysis alone following CPB.

In the present study, the haemostatic effects of tranexamic acid (20 mg/kg body weight bolus after induction of anaesthesia followed by continuous infusion at 2 mg/kg/h), including fibrinolysis and platelet function, were investigated in 22 patients (tranexamic acid group n = 12; control group n = 10) undergoing primary cardiac valve surgery.

Fibrinolysis following CPB was reduced significantly in the tranexamic acid group. Following protamine administration, the reduction of collagen-induced whole blood platelet aggregation was mitigated significantly in the tranexamic acid group compared with the control group (36% reduction in the tranexamic acid group vs 58% in the control group; p = 0.011), although platelet counts did not differ between the two groups.

In conclusion, tranexamic acid not only inhibits fibrinolysis directly, but also may preserve platelet function following CPB.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
J. M. Karski and J. T. Balatbat
Blood Conservation Strategies in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 175 - 188.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J.F. M. Bechtel, J. Prosch, H.-H. Sievers, and C. Bartels
Is the kaolin or celite activated clotting time affected by tranexamic acid?
Ann. Thorac. Surg., August 1, 2002; 74(2): 390 - 393.
[Abstract] [Full Text] [PDF]